Small Interfering RNA Market Growth Drivers and Challenges:
Growth Drivers
-
Rising Popularity of Personalized Medicine – Small interfering RNA (siRNA) has emerged as a promising possibility for precision therapy in cancer and other diseases as it is highly specific and can be easily generated for multiple target genes.
-
Growing Geriatric Population- The elderly population is more susceptible to several age-related diseases such as Alzheimer's disease, Huntington's disease, and Parkinson's disease which may benefit from SiRNA treatment.According to estimates, the proportion of the world's population over 60 years old is anticipated to treble from roughly 11 to more than 22% by 2050.
Challenges
-
High Cost of Developing SiRNA Therapies - Despite their appealing method of action, small interfering RNA therapies confront several hurdles as they are often generated using chemical synthesis, which can be costly if large quantities are required.
-
Stringent Regulations to Obtain Approvals for SiRNA Therapies
- Development of Effective Delivery Methods Can be Challenging
Small Interfering RNA Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
13.9% |
|
Base Year Market Size (2025) |
USD 18.33 billion |
|
Forecast Year Market Size (2035) |
USD 67.36 billion |
|
Regional Scope |
|
